On May 26 2015,Ferncliff Listed DAI AS, a company 
controlled by board member Øystein Stray Spetalen, 
acquired 1 870 subscription rights an average 
purchase price of NOK 10.50,- per subscription right 


After the transaction Øystein Stray Spetalen and 
associated companies hold 2 171 205 subscription 
rights in Vistin Pharma ASA corresponding to 12.7 % 
of the outstanding shares if the subscription rights 
are executed (based on 17 054 935 outstanding 
shares). 
